Reuters logo
3 months ago
BRIEF-NLS Pharma unveils positive Phase 2 data for NLS-1 in adults with ADHD
May 31, 2017 / 4:08 AM / 3 months ago

BRIEF-NLS Pharma unveils positive Phase 2 data for NLS-1 in adults with ADHD

May 31 (Reuters) -

* NLS Pharma unveils positive Phase 2 data for NLS-1 in adults with ADHD, demonstrating significant improvement in symptoms

* NLS Pharma- 55 percent of patients in NLS-1 arm had ADHD symptoms reduced by equal to or above 50 percent, compared to 15.8 percent for placebo

* NLS Pharma- No serious treatment-related adverse events were observed in study, and no discontinuation of NLS-1 by study participants

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below